The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection

OBJECTIVE: The co-infection of HCV/CMV may accelerate the progression of liver diseases and worsen responsiveness to IFN treatment. The Direct-acting antiviral agents (DAAs), currently approved therapy for HCV, may cause a transient change in immune status, favoring the reactivation of other viruses...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Reham M, Gomaa, Ahmed A, El-Meguid, Mai Abd, Hassan, Essam A, Salum, Ghada M, Fares, Hany Mahmoud, El Awady, Mostafa K, Fares, Eman M, Esmat, Gamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375591/
https://www.ncbi.nlm.nih.gov/pubmed/35485698
http://dx.doi.org/10.31557/APJCP.2022.23.4.1365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375591/
https://www.ncbi.nlm.nih.gov/pubmed/35485698
http://dx.doi.org/10.31557/APJCP.2022.23.4.1365

Ejemplares similares